Randomized Controlled Trial

Testing our model with a scientific study in partnership with MIT

Randomized controlled trials (RCT) are the gold standard for scientific evidence. The Camden Coalition is working with health economists at MIT’s Abdul Latif Jameel Poverty Action Lab to conduct an RCT that evaluates the impact of the Coalition’s Care Management Initiatives in Camden.

Led by noted economist Dr. Amy Finkelstein, researchers will analyze the effect of the Coalition’s care management on participants’ hospital readmission rate, compared to that of a control group receiving routine care.

Using real-time hospital data, eligible participants are identified as possible “super-utilizers” of Camden’s healthcare system — individuals with complex, chronic issues that cause high rates of hospital readmission. The goal of our Care Management Initiatives is to reduce readmissions and the associated costs by discovering super-utilizers and helping them meet their complex needs with an intensive, multidisciplinary, team-based intervention.


In the News:

Scientific American: How House Calls Slash Health Care Costs

NPR’s Marketplace: Diagnosis Camden

Freakonomics Podcast: How Do We Know What Really Works in Healthcare?

Stay Informed

Join our mailing list to get the latest updates sent right to your inbox from the Camden Coalition.

Sign Up